Elvitegravir (Vitekta) is an oral HIV antiretroviral (ARV) medication; however, it's no longer available as a tablet on its own because it was discontinued.
Elvitegravir (Vitekta) is an HIV ARV integrase inhibitor. It prevents HIV from inserting itself into your DNA. This way, the virus can't grow and spread in your body.
Gilead, the manufacturer, stopped making elvitegravir (Vitekta) tablets in 2017. They chose to stop making the stand-alone tablet since most people take HIV ARV combination tablets. Their decision had nothing to do with safety of the medication.